HIV

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Surging rates of chlamydia, gonorrhea, and syphilis have affected new populations nationwide.

The 3-in-1 antibody protected laboratory monkeys from SHIV.

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.

Coffee drinking can cut down risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) by half, according to a 5-year study published in the Journal of Hepatology.

Janssen submits new drug application for darunavir-based, once-daily, single-tablet regimen for the treatment of HIV in adults and adolescents who are 12 years of age or older.

As HIV becomes a disease of older Americans, health care professionals need to monitor the age-associated comorbidities among this population.

South African child with HIV reaches 8-plus year survival after only 40 weeks of antiretroviral therapy in infancy.

As HIV becomes a disease of older Americans, it is time for all health care professionals to recognize the age-associated comorbidities unique to this population.

Top news of the day from across the health care landscape.

New PEPFAR strategy supports HIV/AIDS prevention efforts in more than 50 countries.

Traditionally contraindicated in individuals with HIV, thalidomide has utility in aphthous ulcers, gastrointestinal lesions, Kaposi sarcoma, and other HIV-associated developments.

In recent years, thalidomide and similar molecular entities have reentered the clinical milieu and have been approved for several indications.

In Lesotho, more than 67% of all HIV-positive adults ages 15-59 have been able to achieve viral load suppression.

The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g.

Top news of the week from Specialty Pharmacy Times.

Company harnesses CRISPR-based gene editing technology as it enters human clinical trials to treat HIV.

SB239 seeks to reduce the penalty for knowingly exposing sexual partners to HIV to a misdemeanor.

Annually, the Journal of Pharmacy Practice publishes a list of the most significant publications covering infectious disease pharmacotherapy from the previous year.

Findings suggest daily use of Truvada is safe and effective among males aged 15 to 17 years.

Top news of the day from across the health care landscape.

After adjusting for chronological age, the findings showed liver fibrosis was accelerated during peri-menopause compared with pre-menopause.

Top news of the week from Specialty Pharmacy Times.

Accelerated fibrosis in women with a hepatitis C/HIV co-infection begins as early as pre-menopausal years.

The HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.

The degree of the success for HIV remission vary in different parts of the country.